Joseph Stiglitz urges SA to reject compromise on Covid-19 patent waiver
Move is insufficient to make cheap generic vaccines available to developing countries, says economist
Nobel prize-winning economist Joseph Stiglitz has joined a call from activists and researchers urging President Cyril Ramaphosa to revisit SA’s position on a compromise deal that emerged last week at World Trade Organisation talks on a waiver on intellectual property rights (IP) for Covid-19 technologies, saying it will not do enough to make cheap generic vaccines and treatments available to developing countries.
Leaked documents detail a compromise position reached by negotiators for the US, EU, SA and India that could potentially end the near 18-month deadlock over the IP waiver...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.